Le Lézard
Classified in: Health

OMID Holdings, Inc. Issues a Letter to Shareholders


PHILLIPSBURG, N.J., Feb. 26, 2020 /PRNewswire/ -- OMID Holdings, Inc. (OTC Pink: OMID), a publicly-traded health and wellness company, has issued a letter to shareholders. The company intends to provide shareholders with insight into its history as well as the current operations and goals for the future.

Please follow the below link to view the Letter to Shareholders from the Chairman & CEO, Adam Frank.

https://omidholdingsinc.com/disclosure-shareholderletter26feb2020

About OMID Holdings, Inc.: 

OMID Holdings, Inc. is a publicly-traded health and wellness company specializing in the sale and manufacture of CBD-based products. The company operates a manufacturing facility with a FDA-registered and Food Grade Certified clean room in Phillipsburg, NJ. The company is a trusted provider of private label design, development, and manufacturing services for the hemp-based cannabis industry.

For more information, visit: https://omidholdingsinc.com

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

For Investor Relations Please email: [email protected]

SOURCE OMID Holdings, Inc.


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: